Literature DB >> 2104886

Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor.

K W Selmaj1, M Farooq, W T Norton, C S Raine, C F Brosnan.   

Abstract

The effect of cytokines on astrocytes cultured from mature bovine brain was determined both in a serum-containing medium and in a chemically-defined medium. The results showed that in serum-free medium, human TNF and, to a lesser degree, IL-6 and lymphotoxin, were mitogenic for astrocytes. Increased uptake of [3H]thymidine could be detected within 36 h in vitro and its presence in astrocytes was confirmed by autoradiography. In contrast, neither IL-1 alpha nor IL-1 beta induced astrocyte proliferation in serum-free medium but showed some synergistic effect with serum after 72 h. The proliferative effect of TNF and IL-6 was confirmed by cell counting. None of the cytokines tested was toxic for astrocytes as measured by 51Cr release. No mitogenic effect for oligodendroglia, purified from the same source, was detected. The results support a role for products of activated inflammatory cells in the development of astrocyte proliferation that may contribute to the reactive gliosis found in white matter diseases of the central nervous system such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104886

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  102 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Quantitative aspects of reactive gliosis: a review.

Authors:  W T Norton; D A Aquino; I Hozumi; F C Chiu; C F Brosnan
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

3.  Activation of PPARalpha Attenuates IFNgamma and IL-1beta-induced Cell Proliferation in Astrocytes: Involvement of IL-6 Independent Pathway.

Authors:  Jin-Koo Lee; Eun-Min Seo; Sang-Soo Lee; Soo-Hyun Park; Yun-Beom Sim; Jun-Sub Jung; Seon-Mi Kim; Hong-Won Suh
Journal:  Korean J Physiol Pharmacol       Date:  2010-06-30       Impact factor: 2.016

Review 4.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Effects of IL-1 beta on receptor-mediated poly-phosphoinositide signaling pathway in immortalized astrocytes (DITNC).

Authors:  J M Wu; G Y Sun
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

6.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Authors:  L Probert; K Akassoglou; M Pasparakis; G Kontogeorgos; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  PNKP knockdown by RNA interference inhibits herpes simplex virus-1 replication in astrocytes.

Authors:  Lei Yue; Sujie Guo; Xia Cao; Ying Zhang; Le Sun; Longding Liu; Min Yan; Qihan Li
Journal:  Virol Sin       Date:  2013-11-06       Impact factor: 4.327

9.  Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Authors:  Achal S Achrol; Helen Kim; Ludmila Pawlikowska; K Y Trudy Poon; Charles E McCulloch; Nerissa U Ko; S Claiborne Johnston; Michael W McDermott; Jonathan G Zaroff; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

10.  Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.

Authors:  C E Shaw; P R Dunbar; H A Macaulay; T J Neale
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.